Serum HER-2/neu levels in clinical studies with lapatinib in HER-2/neu positive breast cancer

被引：0
|
作者：
Maltzman, J. [1 ]
Blackwell, K. [2 ]
Stein, S. [1 ]
Martin, A. [1 ]
Westland, R. [1 ]
Burstein, H. [3 ]
Gomez, H. [4 ]
Gartner, N. [2 ]
Platek, G. [2 ]
Newmiller, M. [2 ]
Lipton, A. [5 ]
Carney, W. P. [6 ]
机构：
[1] GlaxoSmithKline Inc, Collegeville, PA USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Inst Nacl Enfermedades Neoplas, Lima, Peru
[5] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA
[6] Siemens Healthcare Diagnost, Oncogene Sci Grp, Cambridge, MA USA
来源：
CLINICAL CHEMISTRY | 2008年 / 54卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
C95
引用
收藏
页码：A130 / A130
页数：1
相关论文
共 50 条
  • [21] Her-2/neu oncogen amplification in breast cancer
    Canepa, Mariana
    Deninghoff, Valeria
    Perazzo, Florencia
    Paesani, Fernando
    Nieto, Silvana
    Garcia, Alejandro
    Avagnina, Alejandra
    Elsner, Boris
    MEDICINA-BUENOS AIRES, 2012, 72 (01) : 88 - 89
  • [22] Her-2/neu and Topoisomerase iiα in Breast Cancer
    Tero A.H. Järvinen
    Edison T. Liu
    Breast Cancer Research and Treatment, 2003, 78 : 299 - 311
  • [23] HER-2/neu in locally advanced breast cancer
    Quevedo Gutierrez, Karla Malinalli
    Landa Fernandez, Ana Maria
    Garcia Barrera, Victor
    GACETA MEXICANA DE ONCOLOGIA, 2016, 15 (03): : 108 - 115
  • [24] HER-2/neu oncogene amplification in breast cancer
    Depowski, PL
    Brien, TP
    Sheehan, CE
    Muraca, PJ
    Stylos, S
    Johnson, RL
    Ross, JS
    MODERN PATHOLOGY, 1998, 11 (01) : 18A - 18A
  • [25] Aneusomy 17 in breast cancer: Its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status
    Wang, SJ
    Saboorian, MH
    Frenkel, EP
    Haley, BB
    Siddiqui, MT
    Gokaslan, S
    Hynan, L
    Ashfaq, R
    MODERN PATHOLOGY, 2002, 15 (02) : 137 - 145
  • [26] Serum level of HER-2/neu in patients with gastric cancer: Correlation with HER-2/neu overexpression in gastric carcinoma tissue
    Kono, K
    Naganuma, H
    Sekikawa, T
    Amemiya, H
    Takahashi, A
    Iizuka, H
    Matsumoto, Y
    TUMOR BIOLOGY, 2000, 21 (03) : 139 - 144
  • [27] Serum HER-2/neu testing can identify HER-2/neu positive patients previously classified as negative by tissue testing
    Carney, W. P.
    Brown-Shimer, S.
    Hamer, P. J.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A130 - A130
  • [28] STUDIES OF THE HER-2 NEU PROTOONCOGENE IN HUMAN BREAST-CANCER
    SLAMON, DJ
    PRESS, MF
    GODOLPHIN, W
    RAMOS, L
    HARAN, P
    SHEK, L
    STUART, SG
    ULLRICH, A
    MOLECULAR DIAGNOSTICS OF HUMAN CANCER, 1989, 7 : 371 - 384
  • [29] Automated assay for HER-2/neu in serum
    Payne, RC
    Allard, JW
    Anderson-Mauser, L
    Humphreys, JD
    Tenney, DY
    Morris, DL
    CLINICAL CHEMISTRY, 2000, 46 (02) : 175 - 182
  • [30] Monitoring therapy by serum HER-2/neu
    Schwartz, MK
    Smith, C
    Schwartz, DC
    Dnistrian, A
    Neiman, I
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (04): : 324 - 329
12345